Cited by 163Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

Synapse loss in dementias

Open access
Clare, Ryan, King, Victoria G., Wirenfeldt, Martin, Vinters, Harry V.·2010·Journal of Neuroscience Research

Abstract

Synaptic transmission is essential for nervous system function, and its dysfunction is a known major contributing factor to Alzheimer's‐type dementia. Antigen‐specific immunochemical methods are able to characterize synapse loss in dementia through the quantification of various synaptic proteins involved in the synaptic cycle. These immunochemical methods applied to the study of Alzheimer's disease (AD) brain specimens have correlated synaptic loss with particularly toxic forms of amyloid‐β protein and have also established synapse loss as the best correlate of dementia severity. A significant but comparatively circumscribed amount of literature describes synaptic decline in other forms of dementia. Ischemic vascular dementia (IVD) is quite heterogeneous, and synapse loss in IVD seems to be variable among IVD subtypes, probably reflecting its variable neuropathologic correlates. Loss of synaptic protein has been identified in vascular dementia of the Binswanger type and Spatz‐Lindenberg's disease. Here we demonstrate a significant loss of synaptophysin density within the temporal lobe of frontotemporal dementia (FTD) patients. © 2010 Wiley‐Liss, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jnr.22392

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These tau changes correlate with degeneration of synapses and neuronal loss in frontal and temporal cortices.

    “These changes correlate with degeneration of synapses and neuronal loss in frontal and temporal cortices (Bodea et al., 2016; Clare et al., 2010).”

    From ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids (2021) · cites this paper as Clare et al., 2010

    The ‘Synaptic Proteins and AD’ section reports a correlation between synapse loss and neurons containing neurofibrillary tangles, but also notes that another synaptic marker showed no correlation with tangle density. The FTLD section reports synaptic reductions in frontal and temporal regions. Neither section establishes that tau changes correlate with neuronal loss in those cortices. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Pathologic studies reveal accumulation of filamentous, hyperphosphorylated tau protein in cerebral cortical and hippocampal neurons and glia, and tau redistribution from axons to the somatodendritic compartment.

    “Pathologic studies reveal accumulation of filamentous, hyperphosphorylated tau protein (P-tau) in cerebral cortical and hippocampal neurons and glia, and tau redistribution from axons to the somatodendritic compartment.”

    From ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids (2021) · cites this paper as Clare et al., 2010

    The 'Synaptic Proteins and AD' section mentions neurons containing neurofibrillary tangles, but does not identify their composition or describe tau pathology. Searches for hyperphosphorylated tau and its redistribution from axons to the somatodendritic compartment found no passage addressing the claim in our copy; page numbers were unavailable. (LLM, conf=0.72)

    Experimental — accuracy not yet measured
  • The pathological interplay between loss of synaptic functionality and neurodegeneration remains poorly understood.

    “However, the pathological interplay between loss of synaptic functionality and neurodegeneration remains poorly understood [14].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 61 · Cited by 163

Authors
Clare, R., King, V. G., Wirenfeldt, M., & Vinters, H. V.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Wirenfeldt, Martin
Venue
Journal of Neuroscience Research
Publisher
Wiley
Published
2010-06-07
Volume
88
Issue
10
Pages
2083-2090
ISSN
  • 0360-4012 (ISSN-L)
  • 1097-4547
OpenAlex
W2007804566
Cited by
163
References
61
Citations by year
2026: 4 · 2025: 7 · 2024: 14 · 2023: 11 · 2022: 28 · 2021: 19 · 2020: 10 · 2019: 9 · 2018: 11 · 2017: 9 · 2016: 5 · 2015: 7 · 2014: 7 · 2013: 11 · 2012: 5
FWCI
0.71
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Forsknings- og Innovationsstyrelsen
  • Danish Agency for Science and Higher Education
  • National Institute on Aging (AG 12435, P50AG016570, P50-AG 16570, P01AG012435)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
synaptic loss, Alzheimer's disease, vascular dementia, frontotemporal dementia, synaptophysin, amyloid-beta, synaptic proteins, dementia severity, Binswanger disease, temporal lobe
MeSH terms
Animals, Brain, Dementia, Humans, Synapses

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review